# DESCRIPTION

## FIELD OF THE INVENTION

- introduce Notch inhibitor compounds

## BACKGROUND OF THE INVENTION

- describe Notch signaling
- limitations of current Notch inhibitors
- need for new therapies

## SUMMARY OF THE INVENTION

- introduce new Notch inhibitor compounds

## DETAILED DESCRIPTION OF THE INVENTION

- introduce background of small naturally-occurring molecules
- motivate need for new anti-tumor agents
- describe clustering of library of naturally-occurring compounds
- identify representative molecules for each cluster
- evaluate effects of representative molecules on Notch signaling and cell proliferation
- describe design and synthesis of structural analogues of butein
- analyze results of biochemical and functional assays
- define compounds of formula (I) with anti-tumor activity
- describe preferred embodiments of compounds of formula (I)
- relate to pharmaceutical composition comprising compounds of formula (I)
- compare compound 8 with prior art compounds

### RESULTS

- introduce butein as Notch signal transduction pathway inhibitor
- describe DORS approach for selecting molecules
- summarize Western blotting assays for Notch signaling evaluation
- present results of molecule C (butein) as Notch signaling inhibitor
- describe MTS cellular assay for cell proliferation/vitality evaluation
- introduce design and synthesis of butein derivatives
- describe Claisen-Schmidt condensation for chalcone synthesis
- present results of compound 8 as potent Notch and proliferation inhibitor
- describe structure-activity relationships (SARs) of chalcone derivatives
- analyze SARs of ring A, ring B, and α,β-unsaturated carbonyl system
- describe Materials and Methods for chemoinformatics and clustering algorithm
- characterize naturally-occurring compounds A-H
- outline synthesis methods for chalcone derivatives
- describe general method for protection of 3- and 4-hydroxybenzaldehyde
- describe general procedure for protection of 4′-hydroxyacetophenone
- describe general procedure for Claisen-Schmidt reaction
- describe general procedure for deprotection of chalcones
- characterize compounds of Table 2
- report HRMS data
- report NMR data
- report physical properties
- report synthesis results
- report compound characterization
- report HRMS data
- report NMR data
- report physical properties
- report synthesis results
- report HRMS data
- report NMR data
- report physical properties
- report synthesis results
- report compound characterization
- report experimental results
- describe compound synthesis
- provide chromatographic conditions
- report HPLC analytical separations
- describe cell lines and treatments
- outline proliferation analysis and IG50 calculation
- detail protein extraction and immunoblotting
- describe total RNA isolation and real-time PCR
- provide NMR and HRMS data for compound 15
- provide NMR and HRMS data for compound 16a
- provide NMR and HRMS data for compound 17

